ask="0.30"
ask_size="12000"
average_daily_volume="1652190"
bid="0.28"
bid_size="16500"
book_value="0.17"
change="-0.01"
change_from_200_day_moving_average="-0.06"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-0.83"
change_From_52_week_low="0.01"
change_in_percent="-3.91%"
close="0.29"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.20"
ebitda="-41.64M"
eps_estimate_current_year="-0.13"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.30"
high_52_weeks="1.12"
last_trade_date="1/19/2017"
last_trade_price="0.29"
last_trade_size="130"
last_trade_time="3:59pm"
low="0.29"
low_52_weeks="0.28"
market_capitalization="74.57M"
moving_average_200_day="0.35"
moving_average_50_day="0.31"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.25"
open="0.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-18.07%"
percent_change_from_50_day_moving_average="-7.63%"
percent_change_from_52_week_high="-74.11%"
percent_change_from_52_week_low="+2.84%"
previous_close="0.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.80"
price_per_sales="1.42"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.26"
stock_exchange="NCM"
symbol="PPHM"
volume="1908122"
weeks_range_52="0.28 - 1.12"
